On the use of quantitative modeling to help understand prostate-specific antigen dynamics and other medical problems

Am J Clin Pathol. 2003 Jan;119(1):14-7. doi: 10.1309/AR06-82JH-8B1B-G058.
No abstract available

Publication types

  • Comment
  • Editorial
  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use
  • Brain Neoplasms / pathology
  • Brain Neoplasms / physiopathology
  • Drug Therapy, Combination
  • Glioma / pathology
  • Glioma / physiopathology
  • HIV Infections / drug therapy
  • Humans
  • Male
  • Models, Biological*
  • Neoplasm Invasiveness / physiopathology
  • Prostate-Specific Antigen / physiology*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / pathology

Substances

  • Anti-HIV Agents
  • Prostate-Specific Antigen